Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Theravance Biopharma Inc (TBPH)
Theravance Biopharma Inc (TBPH) Financials

TBPH Theravance Biopharma Inc

9.28

-0.13 (-1.38%)

02 Jan 2025 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-40.595	-52.821	-43.034	-48.801	-63.338	-47.264	177.584	-11.157
Return on Equity (%)	-64.274	-122.647	-677.866	171.699	105.391	62.095	1689.736	-16.858
Return on Invested Capital (%)	-57.593	-72.146	-64.303	-71.14	-90.065	-65.483	-42.866	-49.621
Operating Margin (%)	-368.268	-1710.412	-357.136	-285.797	-336.713	-276.054	-168.36	-81.706
Net Profit Margin (%)	-391.936	-1854.966	-357.005	-322.084	-386.903	-360.554	1698.539	-96.115
Book Value Per Share	6.629	2.118	-0.927	-3.926	-4.722	-4.549	6.773	4.277
Earnings Per Share	-3.609	-5.248	-3.871	-4.147	-4.322	-2.679	13.371	-1.108
Cash Per Share	6.525	1.636	6.789	1.018	1.266	1.209	4.571	0.794
Working Capital Per Share	9.071	5.814	7.799	3.978	4.194	2.57	4.979	2.184
Operating Profit Per Share	0.908	0.218	1.071	1.288	1.117	0.743	0.787	1.153
EBIT Per Share	-3.418	-4.996	-4.06	-4.239	-4.454	-2.681	-1.423	-0.989
EBITDA Per Share	-3.418	-4.996	-4.06	-4.239	-4.454	-2.681	-1.423	-0.989
Free Cash Flow Per Share	-3.61	-5.25	-3.795	-4.149	-4.27	-2.68	13.34	-1.097

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	52.83M	54.38M	55.68M	57.02M	64.33M	74.44M	65.23M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	65.23M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-210.55	N/A	N/A	N/A	-67.386	N/A	N/A
Net Profit Margin (%)	N/A	-212.038	N/A	N/A	N/A	-80.425	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	462.73M
Price to Earnings Ratio	-8.29
Price to Sales Ratio	7.96
Price to Cash Ratio	11.56
Price to Book Ratio	2.15
Dividend Yield	-

Share Statistics

Shares Outstanding	49.17M
Average Volume (1 week)	130.01k
Average Volume (1 Month)	176.63k
52 Week Change	-16.40%
52 Week High	11.71
52 Week Low	7.44

More Ratios Coming Soon!

Theravance Biopharma

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions